Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 118469
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118469
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118469
Table 2 Evaluation of liver and spleen size and lipid content by abdominal magnetic resonance imaging
| Parameter | Evaluation time | Absolute value (multiples of normal) | Change from baseline | % change from baseline |
| Hepatic volume | First visit | 1.79 | ||
| Week 48 | 1.30 | -0.48 | -27.1 | |
| Week 96 | 1.41 | -0.37 | -20.9 | |
| Hepatic lipid content | First visit | 7.52 | ||
| Week 48 | 6.62 | -0.9 | -12.0 | |
| Week 96 | 7.77 | 0.25 | 3.3 | |
| Splenic volume | First visit | 2.24 | ||
| Week 48 | 2.73 | 0.49 | 21.9 | |
| Week 96 | 2.16 | -0.08 | -3.7 | |
| Splenic lipid content | First visit | 1.41 | ||
| Week 48 | 2.23 | 0.24 | 12.1 | |
| Week 96 | 1.37 | -0.62 | -31.2 |
- Citation: Kaplan I, Kor D, Bulut FD, Tumgor G, Alabaz D, Önenli Mungan N. Ten-year enzyme replacement therapy in early childhood-onset lysosomal acid lipase deficiency: A case report. World J Hepatol 2026; 18(5): 118469
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/118469.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.118469